Sanjay K. Gandhi, MD, PhD

Frederic R. Kahl , MD;

William C. Little , MD;

Propensity Score Analysis of Vascular Complications after
Diagnostic Cardiac Catheterization and Percutaneous Coronary Interven

Women have been shown historically to have a greater risk of complications than men following invasive procedures.1–5 The increased incidence of complications in women appears to occur independently of other factors known to influence the...

Women have been shown...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Automated Contrast Injection in Contemporary Practice during Cardiac Catheterization and PCI: Effects on Contrast-Induced Nephr

Renato M. Santos , MD;

Cardiac catheterization and PCI are usually performed by percutaneous access using the femoral artery. Following completion of the procedure, hemostasis is traditionally performed by manual compression, followed by 6 hours of bed rest....

Cardiac catheterization and PCI...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Jason Call , MD;

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Culprit Vessel PCI versus Traditional Cath and PCI for STEMI

Contrast-induced nephropathy (CIN) is a common problem after cardiac catheterization and percutaneous coronary intervention (PCI), and is associated with substantial morbidity and mortality.1–3 The etiology of CIN has not been clearly...

Contrast-induced nephropathy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Stacy H. Graham , MD;

William C. Little , MD;

Renato M. Santos , MD;

Target Lesion Revascularization after Bare-Metal or Drug-Eluting Stents: Clinical Presentations and Outcomes

Achieving rapid reperfusion in patients with ST-elevation myocardial infarction (STEM) has been established as an effective and life-saving treatment for these patients. The mortality benefit of primary percutaneous coronary intervention...

Achieving rapid reperfusion in...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

06/02/2010

Renato M. Santos , MD;

Kevin R. Hayes , MD;

Invasive Hepatocellular Carcinoma With Recurrent Pulmonary Embolism: Use of AngioVac CannulaThrombectomy Device for Mechanical Aspiration

William C. Little , MD;

ABSTRACT: Objective. We sought to examine the clinical presentations and subsequent clinical outcomes of patients undergoing target lesion revascularization (TLR) after either bare-metal stent (BMS) or drug-eluting stent (DES) placement....

ABSTRACT: Objective. We...

06/02/2010

Journal of Invasive Cardiology

07/08/2014

Effect of Tardive Dyskinesia on Quality of Life: Patient-Reported Symptom Severity Is Associated With Physical, Mental, and Social Functioning Deficits

Prasanna Sengodan , MD;

Harpreet Grewal , MD;

We describe the use of a novel AngioVac venous extracorporeal bypass system (AngioDynamics) to remove a part of large right atrial tumor and thrombus in a patient with recurrent pulmonary embolism from hepatocellular carcinoma infiltrating...

We describe the use of a novel...

07/08/2014

Journal of Invasive Cardiology

Background: Tardive dyskinesia (TD), an often-irreversible movement disorder typically caused by exposure to antipsychotics, most commonly affects the face, mouth, and tongue, and may be ...

Avery Rizio , PhD;

Jakob Bjorner , MD, PhD;

Stephen Maher , PhD;

Mark Kosinski , DPM, FIDSA, MA;

Superior In-Hospital and 30-Day Outcomes with Abciximab Versus Eptifibatide: A Contemporary Analysis of 495 Consecutive Percutan

Joseph McEvoy , MD;

Benjamin Carroll , PharmD;

03/01/2019

08/01/2008

Differences in Baseline Characteristics and In-hospital Outcomes in Patients with or without Prior Stroke Undergoing Percutaneou

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

Over the past decade clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition dramatically reduces the ischemic complications of percutaneous coronary intervention (PCI).1–6 Currently, there are 3...

Over the past decade clinical...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Bharathi Upadhya , MD;

David C. Sane , MD;

Efthymios N. Deliargyris , MD;

PCI with and without Abciximab after Upstream Eptifibatide Use: Outcomes in High-Risk Patients

Percutaneous coronary intervention (PCI) is increasingly used in patients with high-risk baseline characteristics.1–4 A prior stroke may identify patients who are at higher risk for post-PCI complications. However, no comparative data exist...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Talal T. Baki , MD;

William C. Little , MD;